#787933
Salix Pharmaceuticals #65649055102

Relistor® Methylnaltrexone Bromide 12 mg / 0.6 mL Injection Single-Use Vial 0.6 mL

Name: Opioid-Induced Constipation (OIC) Treatment
Brand: Relistor®

RELISTOR, VL 12MG/0.6ML 0.6ML

Relistor® Methylnaltrexone Bromide 12 mg / 0.6 mL Injection Single-Use Vial 0.6 mL

Compare

Product Specifications

McKesson #

787933

Manufacturer #

65649055102

Brand

Relistor®

Manufacturer

Salix Pharmaceuticals

Country of Origin

Unknown

Alternate Manufacturer Number

1404219

Application

Opioid-Induced Constipation (OIC) Treatment

Container Type

Single-Use Vial

Dosage Form

Injection

Generic Drug Code

99722

Generic Drug Name

Methylnaltrexone Bromide

NDC Number

65649055102

Product Dating

McKesson Acceptable Dating: we will ship >= 90 days

Strength

12 mg / 0.6 mL

Type

Subcutaneous

UNSPSC Code

51171638

Volume

0.6 mL

Features

RELISTOR is indicated for the treatment of opioid-induced constipation (OIC) for adult patients with chronic non-cancer pain
Each 3 mL vial contains 12 mg of methylnaltrexone bromide in 0.6 mL of water

More Information

MSDS

Professionals Also Viewed

View Full Comparison

No Image

#1130090
Bausch & Lomb #65649015090

Relistor® Methylnaltrexone Bromide 150 mg Tablet Bottle 90 Tablets

RELISTOR is indicated for the treatment of opioid-induced constipation …